SSRIs, the conversation no one has

The first time my GP suggested I try an SSRI, I went home and did not fill the script. I told myself I would try therapy alone first, which was reasonable. I told myself I did not want to mask the feelings, which was reasonable on the surface and silly underneath. I told myself I would be on them forever once I started, which was based on nothing. I told myself I was not the kind of man who needed pills, which was the real reason and the worst one.

Eleven months later I went back, asked for the script, filled it that afternoon, took the first tablet at dinner, and waited.

What followed was a six-month process I wish someone had explained to me before I started, because almost every man I have spoken to since who has been through it tells the same story. The information is out there. The information is just rarely delivered in the form of a friend who has been on them sitting next to you and walking you through what to expect.

This is that conversation, written down.

Why men resist them

The resistance is real and worth naming, because the resistance is what keeps thousands of Australian men away from a treatment that would substantially improve their lives. The resistance has several components, and most of them are wrong, but they are wrong in specific ways that are worth examining.

The first is the masking concern. Many men believe that antidepressants suppress emotion, blunt the highs and lows, and turn you into a flatter version of yourself. There is a kernel of truth in this. Some SSRIs at some doses do produce some emotional blunting in some patients. The kernel becomes a wall when men generalise it into the idea that taking the pill means losing the ability to feel. In practice, for most men on the right SSRI at the right dose, what gets blunted is the bottom of the trough, not the full range. You can still feel grief, joy, irritation, love. What stops is the pit-of-the-stomach despair that has been with you for months.

The second is the dependency concern. Men picture themselves on the pill forever, and they picture themselves unable to come off it, and they picture withdrawal as something dramatic. The reality is that most men who go on SSRIs for a depressive episode come off them within twelve to twenty-four months, with a careful taper, and most of those men do not relapse. Some do, and those men go back on, and that is a perfectly reasonable outcome too. The pill is a tool, not a sentence.

The third is the masculinity concern. This is the deepest one and the hardest to name out loud. The cultural script is that real men do not need help, and within that, real men especially do not need pharmacological help, because that is the help most associated with weakness. The script is wrong, and the men I respect most have all eventually rejected it, and the rejection has been one of the markers of their adulthood rather than the betrayal of it.

The fourth is the libido concern. This one is the most evidence-based of the four, and we will come to it.

What SSRIs actually do

SSRI stands for selective serotonin reuptake inhibitor. The mechanism, simplified, is this. Your brain uses serotonin as one of the neurotransmitters that regulates mood, sleep, appetite, and a few other systems. After serotonin is released into a synapse and does its job, it gets reabsorbed back into the cell that released it. SSRIs slow that reabsorption, which means more serotonin stays in the synapse for longer, which means more signal is passed.

What this does in depression is partially restore the signalling that has been disrupted. It is not a euphoric drug. It does not get you high. It does not feel like anything for the first few weeks, and then, slowly, the bottom of the trough starts to lift. The hopelessness loosens. The cognitive distortions soften. The capacity for ordinary pleasure starts to return.

The drugs available in Australia under the PBS include sertraline, escitalopram, citalopram, fluoxetine, paroxetine, and a few others. Most GPs start with sertraline or escitalopram because the side-effect profile is gentler and the evidence base is strong. Switching between them, if the first one does not work or has tolerable but unwanted effects, is normal and not a failure.

What SSRIs do not do is fix your life. They do not give you new friends. They do not make the divorce undone. They do not write the resume or rebuild the relationship with your son. They lift the floor, which lets you do those things. The doing is still on you.

The 4 to 6 week onset

This is the part that catches most men off guard, because we are conditioned to expect medication to work quickly. SSRIs do not. The mechanism takes time to establish.

The typical timeline looks like this:

• Week one: nothing yet, possibly some side effects (nausea, headache, sleep disruption), possibly a slight worsening of anxiety as the system adjusts.
• Week two: side effects often peak then start to settle, mood often unchanged.
• Week three: subtle shifts, often noticed first by people around you rather than by you.
• Week four to six: the lift starts to be perceptible, the bottom of the trough rises, sleep often improves.
• Week six to eight: substantial improvement in mood and function, side effects mostly settled.
• Week twelve: full effect, decision point about whether dose needs adjusting.

The mistake men make is to abandon the trial in week two because they feel worse, or in week four because they do not yet feel better. The trial needs to run six to eight weeks at a therapeutic dose before a verdict can be passed. If your GP is responsible, they will tell you this and check in with you at the four-week mark. If they do not, ask.

Side effects worth knowing about

The side-effect profile of SSRIs is reasonably well-characterised, and being warned in advance makes most of them easier to live with.

GI effects are the most common in the first two weeks. Nausea, looser stools, sometimes appetite changes. These usually settle. Taking the dose with food helps. If they persist past four weeks, talk to the GP.

Sleep disruption is common in the first two weeks and goes either way. Some men find SSRIs sedating, in which case dose at night. Some find them activating, in which case dose in the morning. Your GP will adjust based on which you experience.

Headaches are common early and usually settle. Hydrate. If they persist, mention it.

Sweating, particularly night sweats, is reported by a meaningful minority of men and tends to persist. Most men find it tolerable. A change of bedding and a fan helps.

Sexual side effects are the ones men most worry about and the ones that get the least honest discussion in the GP's office. They are real. The literature suggests something between thirty and sixty per cent of men on SSRIs experience some sexual effect, including reduced libido, delayed ejaculation, or erectile changes. Some men find these mild and tolerable. Some find them substantial and distressing. The effects are usually dose-related, often improve over time, and resolve fully when the medication is stopped.

If sexual side effects are intolerable, there are options. Lowering the dose sometimes helps. Switching to a different SSRI sometimes helps, because the effect varies between drugs. Switching to a different class entirely, such as bupropion (which is not as readily available in Australia for depression alone but is sometimes prescribed) or mirtazapine, sometimes helps. Adding a low dose of a second medication can help in some cases. The conversation needs to be had honestly with your GP, not buried under awkwardness.

Other less common effects include emotional blunting (mentioned earlier, can be addressed with dose change), weight changes (usually small, varies by drug), and discontinuation symptoms when stopping (manageable with a slow taper).

The trial-and-error nature

About sixty per cent of men respond well to the first SSRI they try. The remaining forty per cent need a switch. Of those who switch, another sixty per cent respond to the second drug. After that, the picture becomes more complex and usually involves a psychiatrist rather than a GP.

The implication is that "SSRIs did not work for me" after one trial is not a final answer. It is a data point. Your serotonin system is configured slightly differently to the next bloke's, and the response to a specific molecule is partly genetic and partly idiosyncratic. The trial-and-error is normal. The patience required is real. The eventual fit is usually findable.

If you have tried two SSRIs at adequate dose for adequate duration and neither has worked, ask your GP for a referral to a psychiatrist. The Medicare-rebated psychiatry pathway is more limited than psychology, with longer wait times in most cities, but the assessment is worth it. Other classes of antidepressant, including SNRIs, atypicals, and the older tricyclics, may suit you better.

The PBS coverage

For most working-age Australian men, SSRIs are heavily subsidised under the Pharmaceutical Benefits Scheme. The general patient co-payment, as of recent years, sits at around forty dollars per script, and the concession rate is substantially lower. A month of sertraline or escitalopram costs less than a single takeaway dinner. Cost is rarely the barrier. The barrier is almost always the script-not-filled, which is a different kind of cost.

If you have a Health Care Card, the cost is lower again. If you reach the Safety Net threshold, the cost drops further. The financial side of this treatment is one of the more functional parts of the Australian system, and there is no good reason to factor cost into the decision unless your situation is exceptional.

The "do I need them forever" question

This is the question every man asks, and the answer is almost always no.

The standard recommendation in the Australian and international guidelines is to remain on an SSRI for six to twelve months after symptom remission for a first depressive episode. So if your depression resolved at the four-month mark and you continue for another nine months on top of that, you are looking at thirteen months total before considering a taper. The taper itself is gradual, usually over four to eight weeks, supervised by your GP.

For a second episode, the recommendation often extends to two years on the medication after remission. For a third episode or for a chronic recurrent picture, longer-term maintenance becomes more sensible, and a small minority of men do remain on SSRIs for years or indefinitely. That minority is not the majority outcome.

Most men go on, get well, stay well for a while, taper off, and stay off. Some come back to them later in life during another major shift. That cycle is not a failure. It is a useful relationship with a useful tool.

The data on combining medication and therapy

For mild depression, therapy alone is often as effective as medication alone. For moderate depression, the two are roughly comparable, with combination therapy outperforming either by a modest margin. For severe depression, the combination significantly outperforms either alone, and medication is usually necessary to bring the system into a state where therapy can do its work.

The practical implication is that if your depression is moderate to severe, the question is not medication or therapy. The question is medication and therapy. The two work on different mechanisms. The medication addresses the chemistry. The therapy addresses the patterns. Removing either component reduces the overall lift.

Most Australian men on SSRIs benefit from concurrent psychology, and the Mental Health Care Plan that gives you ten subsidised sessions per year is designed exactly for this combination. Use both arms of the system.

A short list of things worth knowing

• Drinking on SSRIs is not contraindicated but it does interact. Alcohol is a depressant and undermines the work the SSRI is doing. Most GPs recommend reducing alcohol substantially during the first three months.
• Other medications can interact, particularly some pain medications and some migraine drugs. Tell your GP everything you take, including supplements.
• Stopping suddenly is unwise. Discontinuation symptoms include dizziness, sensory changes, mood swings, and flu-like symptoms. Always taper with medical supervision.
• The first GP appointment about this should be a long one, not a standard fifteen-minute slot. Book accordingly.
• A second opinion is reasonable. If your GP rushes the conversation, find another.

HAVE THE CONVERSATION OUT LOUD.

The men I know who went on an SSRI during a hard period almost universally describe two things in retrospect. First, the regret that they waited as long as they did. Second, the quiet relief that the floor came up. The pill is not the cure. The pill is the floor that lets you walk again.

If you have been considering this for months and have not yet asked, this week is the week. Book the long appointment. Have the honest conversation. Fill the script. Set a check-in for week four. Be patient through the onset. Tell your GP the truth about side effects when they show up.

Lift the floor. Walk again.